Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Bio-Rad Laboratories (BIO)
NYSE:BIO
Bio-Rad Laboratories (BIO) Stock Price & Analysis
601 Followers
BIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$344.63 - $670.62
Previous Close$476.94
Volume82.08K
Average Volume (3M)175.13K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$1.85B
Total Debt (Recent Filing)$1.38B
Price to Earnings (P/E)-2.4
Beta1.08
Next EarningsFeb 16, 2023
EPS Estimate$3.45
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$571.00
EPS (TTM)-201.81
Shares Outstanding29,824,130
R-Squared0.27
Standard Deviation0.09
10 Day Avg. Volume135,654
30 Day Avg. Volume175,131
Price to Book (P/B)1.80
Price to Sales (P/S)5.66
Price to Cash Flow (P/CF)53.40
P/FCF Ratio-222.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside19.72% Upside
Rating ConsensusModerate Buy
Alpha0.00736
Number of Analyst Covering1
Bio-Rad Laboratories News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BIO FAQ
What was Bio-Rad Laboratories’s price range in the past 12 months?
Bio-Rad Laboratories lowest stock price was $344.63 and its highest was $670.62 in the past 12 months.
What is Bio-Rad Laboratories’s market cap?
Currently, no data Available
When is Bio-Rad Laboratories’s upcoming earnings report date?
Bio-Rad Laboratories’s upcoming earnings report date is Feb 16, 2023 which is in 8 days.
How were Bio-Rad Laboratories’s earnings last quarter?
Bio-Rad Laboratories released its earnings results on Oct 27, 2022. The company reported $2.6 earnings per share for the quarter, missing the consensus estimate of $2.782 by -$0.182.
Is Bio-Rad Laboratories overvalued?
According to Wall Street analysts Bio-Rad Laboratories’s price is currently Undervalued.
Does Bio-Rad Laboratories pay dividends?
Bio-Rad Laboratories does not currently pay dividends.
What is Bio-Rad Laboratories’s EPS estimate?
Bio-Rad Laboratories’s EPS estimate is $3.45.
How many shares outstanding does Bio-Rad Laboratories have?
Bio-Rad Laboratories has 24,749,308 shares outstanding.
What happened to Bio-Rad Laboratories’s price movement after its last earnings report?
Bio-Rad Laboratories reported an EPS of $2.6 in its last earnings report, missing expectations of $2.782. Following the earnings report the stock price went down -7.979%.
Which hedge fund is a major shareholder of Bio-Rad Laboratories?
Among the largest hedge funds holding Bio-Rad Laboratories’s share is Fisher Asset Management LLC. It holds Bio-Rad Laboratories’s shares valued at 62M.
---
Bio-Rad Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$571.00
$571.00
Blogger Sentiment
Bullish
BIO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $47.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.69%
12-Months-Change
Fundamentals
Return on Equity
-50.74%
Trailing 12-Months
Asset Growth
-39.57%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
---
---